News

December 7, 2010

Champions Biotechnology Announces Master Service Agreement with Teva Pharmaceutical Industries, Ltd. for the Evaluation of a Novel Oncology Compound

READ MORE
October 28, 2010

Champions Biotechnology Reports Additions to its Management Team

READ MORE
September 10, 2010

Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results

READ MORE
September 8, 2010

Champions Biotechnology Announces Agreement with Cephalon for the Evaluation of a Novel Oncology Compound using Predictive Biomerk TumorGraft™ Platform

READ MORE
April 20, 2010

Champions Biotechnology, Inc. and Morphotek®, Inc. Announce Agreement for an Oncology Evaluation Using Biomerk Tumorgraft Platform

READ MORE
March 17, 2010

Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results

READ MORE
December 15, 2009

Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results

READ MORE
November 18, 2009

Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology

READ MORE
November 12, 2009

Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development

READ MORE
October 27, 2009

Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer

READ MORE